An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2010
At a glance
- Drugs Cinacalcet (Primary)
- Indications Hyperparathyroidism; Parathyroid cancer
- Focus Therapeutic Use
- Sponsors Amgen
- 05 Dec 2006 Status change
- 18 Aug 2005 New trial record.